Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis
Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis
复制标题
DOI：
10.1016/s0369-8114(00)00023-7
复制
发表时间：
2001-03-01
影响因子：
--
通讯作者：
Ridell, B
中科院分区：
文献类型：
--
作者：
Kutti, J;Ridell, B
关于骨髓增生性疾病（MPD）的流行病学，文献中几乎没有可靠的信息。目前的工作试图研究MPD的发病率在哥德堡市，瑞典在一个为期十年。因此，我们回顾性地评估了1983-1992年研究期间患有真性红细胞增多症（PV）、原发性血小板增多症（ET）和特发性骨髓纤维化（IM）的受试者人数。PV的年计算发病率为2.8/100，000人群。对于ET和IM，相应的数字分别为1.5和0.4。PV的结果证明了迄今为止文献中报告的最高发生率。至于ET和IM，我们的研究结果在很大程度上同意以前在文献中报道的。(C)2001年，Elsevier SAS科学与医学版。
As to the epidemiology of myeloproliferative disorders (MPD) very little solid information is available in the literature. The present work attempted to study the incidence of MPD in the city of Goteborg, Sweden during a period of ten years. Therefore, retrospectively we assessed the number of subjects afflicted with polycythaemia vera (PV), essential thrombocythaemia (ET) and idiopathic myelofibrosis (IM) over the study period of 1983-1992. The yearly calculated incidence for PV was 2.8 per 100 000 population. For ET and IM the corresponding figures were 1.5 and 0.4, respectively. The results for PV demonstrated the highest incidence rate reported in literature so far. As to ET and IM our results largely agree with what has been reported previously in the literature. (C) 2001 Editions scientifiques et medicales Elsevier SAS.